The ABPI's Chief Executive, Mike Thompson, has announced that he is due to retire at the end of 2019.
The Government has announced further details for how they will support pharmaceutical companies’ investments in the development of drugs that will treat AMR infections.
New figures published today by the ABPI show that the pharmaceutical industry continues to invest significantly in UK research and development, working with healthcare professionals and organisations to improve care for NHS patients.
A written ministerial statement from the Cabinet Office has been published this afternoon, along with a letter giving an update on the Government’s 'no deal' planning and guidance.
The Office for Life Sciences has today published its annual Life Science Competitiveness Indicators, which highlight the importance of the Industry to the UK economy.
Outgoing Chief Medical Officer Professor Dame Sally Davies has been named as UK Special Envoy on antimicrobial resistance (AMR), working across all sectors including includes health, agriculture and the environment to tackle the global health threat.
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
The ABPI has published a new guide for pharmaceutical companies working with patients.
The ABPI welcomes the news of the Government’s decision to reject three significant recommendations made by the Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) group following consultation with charities, patient groups, health bodies and organisations, and...
In National Careers Week, Charlotte Hardy, medicinal chemist from GSK gives her perspective on what it’s like to work in the pharmaceutical sector